EXECUTIVE TEAM
Our executive team is composed of successful developers of companies and commercial technologies.
Mike Blue
President, CEO, Board Member
18 years of medical device experience and commercial leadership.
Boston Scientific, superDimension (COV), NeuWave Medical (JNJ)
Josh Stopek, PhD
VP of Research and Development
16 years of global R&D and business development leadership.
US Surgical, Covidien, Medtronic
Dan Bulver
VP of Operations
Over 30 years of global manufacturing and operations leadership in medical device.
SCIMED (BSC), Microvena (ev3), superDimension (COV), Medtronic
Mike Daniel
VP of Regulatory and Clinical Affairs
Over 60 cleared 510(k)’s for over 20 companies in the last 30 years
Intuitive Surgical, SurgiQuest, Auris Robotics
Jon Freeman
CFO
25 years of financial and operations experience
KPMG, ev3 (COV), Medafor (C.R. Bard)
Fred Lee Jr., MD
HistoSonics Senior Medical Advisor
Professor of Radiology, Biomedical Engineering, and Urology; and the past Chief, Abdominal Imaging and Oncologic Imaging at the University of Wisconsin.
Co-founder NeuWave Medical (JNJ)
Akhil Tripathi, PhD
VP of Global Business Development
Serial MedTech entrepreneur and innovator.
SnooZeal Ltd., Caliper Technologies, Armighorn Spine, Stryker – Navigation
Josh King
VP of Marketing
15 years of global marketing and strategy experience
BrainLab, Covidien, NeuWave Medical (JNJ)
BOARD
Our Board has deep experience in creating value in medical technology.
Jim Adox, Board Chairman
Managing Director
Venture Investors, LLC
Mike Blue
HistoSonics President & CEO
Fred Lee Jr., MD
HistoSonics Senior Medical Advisor
Tom Tefft
Former President, Medtronic Neuromodulation
Gerry Brunk
Managing Director
Lumira Ventures
Greg Sorensen
Vice President of Strategy and Business Development
Varian Medical Systems
Kadir Kadhiresan, PhD
Vice President
Johnson & Johnson Innovation – JJDC, Inc.
INVESTORS
We are backed by venture capital firms with expertise in healthcare technology.
Venture Investors
Premier provider of seed and early-stage venture capital to healthcare and technologies companies.
Hatteras Venture Partners
Supporting breakthrough science and entrepreneurial innovation that transform human health.
Fletcher Spaght Ventures
Investing in promising new ventures in emerging technologies with high growth potential.
Early Stage Partners
Provides early stage venture capital to promising entrepreneurial companies in healthcare technology and other fields.
TGap Ventures
Helps entrepreneurs define, develop, grow, and build value in their businesses, principally in medicine healthcare technology.
Johnson & Johnson Innovation, JJDC
